Baojikuang Health (01246): Applies for judicial review approval to the High Court, continues suspension of trading.

Wisdom Financial News APP report, Baoji Health (01246) announced on June 3, 2026: (a) the company has filed for a judicial review permit with the High Court to overturn the decision of the Listing Review Committee and apply for any other compensation, relief or instructions that the High Court may grant; and (b) the company has informed the Stock Exchange of all relevant judicial review procedures and reasons for seeking judicial review.